GSK690693 is primarily utilized in the field of cancer research due to its role as a potent inhibitor of the AKT pathway, which is crucial in cell survival and proliferation. By blocking this pathway, it helps in studying the effects of AKT inhibition on tumor growth and progression. Researchers employ this compound to understand the mechanisms underlying resistance to cancer therapies and to explore potential strategies to overcome such resistance. Additionally, GSK690693 is used in preclinical studies to evaluate its efficacy in combination with other therapeutic agents, aiming to enhance the overall treatment outcomes for various cancers. Its application extends to the development of targeted therapies that can specifically inhibit pathways involved in cancer cell survival, thereby providing a more precise approach to cancer treatment.